NOV 20, 2018 1:00 AM CET

Advanced optical hematology technology for elevated analytical performance

Sponsored by: Abbott
Speaker

Abstract
DATE:  November 20, 2018
 
Europe: 09:00 GMT/WET 10:00 CET / 12:00 MST
Middle East:  12:00 TRT / 13:00 GST
Asia/Pacific:  17:00 SGT / 14:30 IST
Americas:  06:00 ART / 01:00 PDT / 04:00 EDT
 
Today, hematology analyzers can collect vast amounts of data about cell characteristics, that subsequently improve disease detection. Advanced systems can perform a complete blood count (CBC) and classify multiple cell types, including more than the normal five subclasses of mature white blood cells. They also produce improved flagging of abnormal results to aid further microscopic review. Multi Angle Polarized Scatter Separation (MAPSS™), an optical technology is utilized in Abbott’s hematology analyzers. Abbott’s latest hematology system employs an advanced version of MAPSS technology, as well as a learning algorithm to provide enhanced differentiation of blood cells. In addition, analysis of red blood cells and platelets are performed using entirely optical technology, allowing for the introduction of additional parameters.
 
In this HIT SERIES, Dr. Mukhtar will review the general principles and capabilities of Abbott’s Advanced MAPSS technology and review a series of cases produced by the hematology system that employs Advanced MAPSS.
 
Learning Objectives:
 
  • Describe Advanced MAPSS technology: measurement principles, detectors, reportable parameters, morphological flags, workflow efficiency and demonstration of relevant cases.
  • Discuss RBC/PLT separation using Advanced MAPSS in comparison to impedance and that enables additional parameters. Efficiently demonstrate the relevant cases of microcytic hypochromic anemia and schistocytes with intravascular hemolysis.
  • Review platelet analysis, flags and reticulated platelets in comparison to CD61 and impedance methods with a case demonstration using Advanced MAPSS technology.
 
Don't miss a future webinar. Sign up today to receive updates.
 
 
 

Show Resources
You May Also Like
NOV 30, 2021 10:00 AM PST
C.E. CREDITS
NOV 30, 2021 10:00 AM PST
Date: November 30, 2021 Time: 10:00am (PDT), 1:00pm (EDT) The prevalence of thyroid disease worldwide has served as a catalyst for healthcare providers to study various tools and methods to...
OCT 20, 2021 10:00 AM PDT
C.E. CREDITS
OCT 20, 2021 10:00 AM PDT
Date: October 20, 2021 Time:10:00am (PDT), 1:00pm (EDT) As the prevalence of Diabetes continues to rise in many areas across the globe, healthcare providers continue to look for methods that...
NOV 17, 2021 8:00 AM PST
C.E. CREDITS
NOV 17, 2021 8:00 AM PST
Date: November 17, 2021 Time: 8:00am (PDT), 11:00am (EDT) From waste disposal to promising biomarkers and therapeutic agents, exosomes and other extracellular vesicles are valuable in resear...
SEP 09, 2021 8:00 AM PDT
C.E. CREDITS
SEP 09, 2021 8:00 AM PDT
Date: September 09, 2021 Time: 8:00am (PDT), 11:00am (EDT) Human pluripotent stem cells (PSCs) hold great potentials in regenerative therapies. In this webinar, Chao will first present the c...
JAN 13, 2022 9:00 AM PST
C.E. CREDITS
JAN 13, 2022 9:00 AM PST
Date: January 13, 2022 Time: 09:00am (PST), 12:00pm (EST) Recently, the Infectious Disease Society of America released guidance on how to approach treatment of infections caused by multidrug...
DEC 09, 2021 11:00 AM PST
C.E. CREDITS
DEC 09, 2021 11:00 AM PST
Date: December 09, 2021 Time: 11:00am (PDT), 2:00pm (EDT) The burden of antimicrobial resistance (AMR) has been acknowledged worldwide by leading health institutes. Besides the need for new...
NOV 20, 2018 1:00 AM CET

Advanced optical hematology technology for elevated analytical performance

Sponsored by: Abbott


Show Resources
Loading Comments...
Show Resources